MATTHEW BURKETT: Open Payments
NPI 1689654006 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 92 payments from 10 companies in 2025. Trend: 2023 $532 · 2024 $812 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 56 | $908 |
| ANI Pharmaceuticals, Inc. | 12 | $241 |
| Alkermes, Inc. | 9 | $122 |
| Indivior Inc. | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Invivyd Inc | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Novo Nordisk Inc | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: KRYSTEXXA, PURIFIED CORTROPHIN GEL, ARISTADA, SUBLOCADE, CAPLYTA, PEMGARDA, SHINGRIX, UPLIZNA.
Industry payments across PA — which companies pay providers there.
